Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,863,619 | 3,023,172 | 3,154,263 | 2,403,814 | 2,777,334 |
| Marketable Securities | 349,978 | 407,166 | 260,896 | 187,137 | 377,147 |
| Receivables | 3,577,397 | 3,184,174 | 3,084,455 | 3,231,662 | 3,595,674 |
| Inventories | 2,335,159 | 2,406,340 | 2,222,641 | 2,157,310 | 2,131,073 |
| Other current assets | -1 | 0 | 0 | 0 | 0 |
| TOTAL | $9,126,152 | $9,020,852 | $8,722,255 | $7,979,923 | $8,881,228 |
| Non-Current Assets | |||||
| PPE Net | 5,354,020 | 5,234,224 | 4,716,235 | 4,459,167 | 4,484,600 |
| Investments And Advances | 267,648 | 349,654 | 296,096 | 292,536 | 326,474 |
| Intangibles | 505,068 | 413,170 | 391,491 | 397,361 | 403,300 |
| Other Non-Current Assets | 294,838 | 448,878 | 342,241 | 381,157 | 398,693 |
| TOTAL | $6,421,573 | $6,445,926 | $5,746,063 | $5,530,221 | $5,613,068 |
| Total Assets | $15,547,720 | $15,466,780 | $14,468,320 | $13,510,140 | $14,494,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 257,319 | 41,080 | 248,916 | 87,904 | 34,029 |
| Accounts payable and accrued liabilities | 852,159 | 715,740 | 629,610 | 542,339 | 893,235 |
| Other current liabilities | 5,393,969 | 5,493,976 | 5,054,926 | 5,758,083 | 5,530,892 |
| TOTAL | $7,147,807 | $7,130,066 | $6,481,570 | $7,012,690 | $7,048,990 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 704,512 | 704,680 | 738,908 | 716,426 | 716,401 |
| TOTAL | $833,020 | $919,244 | $823,064 | $718,291 | $718,332 |
| Total Liabilities | $7,980,826 | $8,049,310 | $7,304,633 | $7,730,981 | $7,767,322 |
| Shareholders' Equity | |||||
| Common Shares | 75,950 | 79,000 | 73,950 | 73,134 | 75,786 |
| Retained earnings | 7,439,606 | 7,151,396 | 6,953,371 | 5,841,973 | 6,852,095 |
| Other shareholders' equity | 53,342 | 188,072 | 137,364 | -133,943 | -199,907 |
| TOTAL | $7,566,898 | $7,417,468 | $7,163,685 | $5,779,164 | $6,726,974 |
| Total Liabilities And Equity | $15,547,724 | $15,466,778 | $14,468,318 | $13,510,145 | $14,494,296 |